Inhibition of MALT1 and BCL2 induces synergistic anti-tumor activity in models of B cell lymphoma.
Plotnik JP, Richardson AE, Yang H, Rojas E, Bontcheva V, Dowell C, Parsons S, Wilson A, Ravanmehr V, Will C, Jung P, Zhu H, Partha SK, Panchal SC, Mali RS, Kohlhapp FJ, McClure RA, Ramathal CY, George MD, Jhala M, Elsen NL, Qiu W, Judge RA, Pan C, Mastracchio A, Henderson J, Meulbroek JA, Green MR, Pappano WN.
Plotnik JP, et al. Among authors: jung p.
Mol Cancer Ther. 2024 Mar 20. doi: 10.1158/1535-7163.MCT-23-0518. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 38507740